Articles

Viewing page: 1 | 2 | 3

2/3/2010 TOLERABILITY OF TREATMENT WITH NGX-4010 (QUTENZA®) IN CONJUNCTION WITH PRE-PATCH TOPICAL APPLICATION OF A LIDOCAINE 2.5%/PRILOCAINE 2.5% ANESTHETIC CREAM

2/3/2010 TOLERABILITY OF NGX-4010 (QUTENZA®) IN CONJUNCTION WITH THREE TOPICAL ANESTHETIC FORMULATIONS FOR THE TREATMENT OF NEUROPATHIC PAIN

2/3/2010 SELECT MEDICAL-LEGAL REVIEWS OF UNINTENTIONAL OVERDOSE DEATHS

2/3/2010 USE OF AN ALGORITHM APPLIES TO URINE DRUG SCREENING TO ASSESS ADHERENCE TO A HYDROCODONE REGIMEN

2/3/2010 USE OF AN ALGORITHM APPLIED TO URINE DRUG SCREENING TO ASSESS ADHERENCE TO AN OXYCONTIN® REGIMEN

12/17/2009 NEUROGESX RECEIVES FDA APPROVAL OF QUTENZA(TM) (CAPSAICIN) 8% PATCH FOR TREATMENT OF POSTHERPETIC NEURALGIA (PHN)

12/17/2009 NKTR-118 SIGNIFICANTLY REVERSES OPIOID-INDUCED CONSTIPATION

12/17/2009 PRISM STUDY SURGICAL TECHNIQUE POSTER FOR NANS

2/4/2009 PHARMACOGENETICS IN PAIN MANAGEMENT: THE CLINICAL NEED. LYNN R. WEBSTER, MD

3/19/2008 LIFETREE CLINICAL RESEARCH HIRES NEW CLINICAL RESEARCH PHARMACIST

12/10/2007 DRUG HOPES NOT TO PASS TEST. ALPHARMA DEVELOPING TAMPER-RESISTANT PAIN PILL TO HELP DETER ABUSE.

11/16/2007 ALPHARMA DEVELOPING TAMPER-RESISTANT PAIN PILL TO CURB ABUSE

11/15/2007 DR. WEBSTER MANUSCRIPT HAS BEEN ACCEPTED FOR PUBLICATION IN PAIN

9/10/2007 PAIN PATIENTS AT RISK FOR SLEEP APNEA

8/15/2007 EXPERT OPINION PTI 821 SUSTAINED RELEASE OXYCODONE USING GEL CAP TECHNOLOGY

© Copyright Lifetree Clinical Research® 2007